Phase I, Multicenter, Dose Escalation Study of DCR-MYC in Patients With Solid Tumors, Multiple Myeloma, or Lymphoma
Novo Nordisk A/S
Novo Nordisk A/S
University of Virginia
University of Wisconsin, Madison
Wake Forest University Health Sciences
Nicklaus Children's Hospital f/k/a Miami Children's Hospital
National Institutes of Health Clinical Center (CC)
Wake Forest University Health Sciences
University of Louisville
Burzynski Research Institute
University of Southern California
Novartis
Novartis
Novartis
National Cancer Institute (NCI)
Case Comprehensive Cancer Center